GH1 and type 2 diabetes mellitus: In other conditions, such as Turner syndrome, GH-related insulin resistance may normalize after discontinuation (34), though large retrospective studies in pediatric populations have reported persistent T2DM (35, 36) and cardiovascular risks post-treatment (37).